Definition of Particle Visibility Threshold in Parenteral Drug Products—Towards Standardization of Visual Inspection Operator Qualification

References

1. 1.↵
   U.S. Pharmacopeial Convention. General Chapter <790> Visible Particulates in Injections. USP—NF 2023, https://www/uspnf.com.
2. 2.↵
   Council of Europe, Particulate Contamination: Visible Particles, Chapter 2.9.20. In European Pharmacopoeia (Ph. Eur.), 6th Edition, Council of Europe: Strasbourg, France, 2008.
3. 3.↵
   Ministry of Health Labour and Welfare of Japan, Tests for Preparations—6.06: Foreign Insoluble Matter Test for Injections. In The Japanese Pharmacopoeia, 17th Edition (English Version), MHLW: Tokyo, 2016.
4. 4.↵
   1. Knapp J. Z.,
   2. Kushner H. K.

   Generalized Methodology for Evaluation of Parenteral Inspection Procedures. PDA J. Pharm. Sci. Technol. 1980, 34 (1), 14–61.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Mazaheri M.,
   2. Saggu M.,
   3. Wuchner K.,
   4. Koulov A. V.,
   5. Nikels F.,
   6. Chalus P.,
   7. Das T. K.,
   8. Cash P. W.,
   9. Finkler C.,
   10. Levitskaya-Seaman S. V.,
   11. Case J.,
   12. Parsons J.,
   13. Gonzalez K.

   Monitoring of Visible Particles in Parenteral Products by Manual Visual Inspection - Reassessing Size Threshold and Other Particle Characteristics That Define Particle Visibility. J. Pharm. Sci. 2024, 113 (3), 616–624. https://doi.org/10.1016/j.xphs.2023.10.002.

   OpenUrlPubMed
6. 6.↵
   1. Mathonet S.,
   2. Mahler H.-C.,
   3. Esswein S. T.,
   4. Mazaheri M.,
   5. Cash P. W.,
   6. Wuchner K.,
   7. Kallmeyer G.,
   8. Das T. K.,
   9. Finkler C.,
   10. Lennard A.

   A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug Products. PDA J. Pharm. Sci. Technol. 2016, 70 (4), 392–408.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Melchore J. A.,
   2. Berdovich D.

   Considerations for Design and Use of Container Challenge Sets for Qualification and Validation of Visible Particulate Inspection. PDA J. Pharm. Sci. Technol. 2012, 66 (3), 273–284.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Shabushnig J.,
   2. Miller R.,
   3. Watson R

   , PDA Research: 2023 PDA Visual Inspection Survey; PDA: Bethesda, MD, 2023.
9. 9.↵
   U.S. Pharmacopeial Convention. General Chapter <1790> Visual Inspection of Injections. USP—NF 2023, https://www/uspnf.com.
10. 10.↵
    1. Bush T.,
    2. Ayres J.,
    3. Begat C.,
    4. Burazer A.,
    5. DeGrazio F.,
    6. Flynn C.,
    7. Harianawala A.,
    8. Kinsey P.,
    9. Miller J.,
    10. Perry A.,
    11. Shabushnig J.,
    12. Song X.,
    13. Soukiassian H.,
    14. Spasoff A.,
    15. Stanton A.,
    16. Streich D.,
    17. Watson R.

    Technical Report No. 85: Enhanced Test Methods for Visible Particle Detection and Enumeration on Elastomeric Closures and Glass Containers; Bethesda, MD, 2021.
11. 11.↵
    1. Shabushnig J.,
    2. Melchore J. A.,
    3. Geiger M.,
    4. Chrai S.,
    5. Gerger M. E.

    A Proposed Working Standard for the Validation of Particulate Inspection in Sterile Solutions, 1994.
12. 12.↵
    1. Dunham A.

    Visible Particulate Matter Detection in LVIs., 2008.
13. 13.↵
    1. Goldstein E. B.

    Sensation and Perception, 8th ed.; Cengage Learning, 2009.
14. 14.↵
    1. Fang X.,
    2. Luo Q.,
    3. Zhou B.,
    4. Li C.,
    5. Tian L.

    Research Progress of Automated Visual Surface Defect Detection for Industrial Metal Planar Materials. Sensors 2020, 20 (18), 5136. https://doi.org/10.3390/s20185136.

    OpenUrlPubMed
15. 15.↵
    1. Rodríguez-Gonzálvez P.,
    2. Rodríguez-Martín M.,
    3. Ramos L. F.,
    4. González-Aguilera D.

    3D Reconstruction Methods and Quality Assessment for Visual Inspection of Welds. Autom. Constr. 2017, 79 49–58. https://doi.org/10.1016/j.autcon.2017.03.002.

    OpenUrl